secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeward Ltd. (LFWD)
CIK:        0001607962
Form:       8-K
Filed at:   2025-11-14T23:59:59+00:00
Accession:  0001178913-25-003837
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 2.02, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifeward Q3 revenue $6.2M (+1% YoY); net loss $0.20/shr; secures $3M loan from Oramed
--------------------------------------------------------------------------------

- Revenue $6.2M (+1% YoY); traditional products up 24% to $3.1M; AlterG down 15% to $3.1M.
- GAAP net loss $3.2M ($0.20/shr); non-GAAP net loss $3.0M ($0.19/shr) vs $4.0M ($0.45/shr) YoY.
- Cash used in ops $3.8M (down from $4.5M YoY); unrestricted cash $2.0M at quarter end.
- Entered $3.0M secured loan from Oramed at 15%, convertible at $0.45/shr, matures May 2026.
- Reaffirmed FY2025 guidance: revenue $24-26M; non-GAAP net loss $12-14M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1607962/000117891325003837/0001178913-25-003837-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1607962/000117891325003837/zk2534022.htm
  HTML page:      https://secwatch.observer/filing/0001178913-25-003837

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer